The “extra-hepatic” acromegaly hypothesis, which has been put forth by Neggers and colleagues, proposes that SSA effect reduces proportionally more hepatic IGF1 production compared with GH production, leading to disproportionately elevated peripheral GH responsible for perpetuating some acromegaly symptoms (29). The gene discussed is IGF1; the disease is acromegaly.